Approaches and Best Practices for Managing Cancer Pain within the Constraints of the COVID-19 Pandemic in India.
Neoplasms
pain management
severe acute respiratory syndrome coronavirus 2
Journal
Indian journal of palliative care
ISSN: 0973-1075
Titre abrégé: Indian J Palliat Care
Pays: United States
ID NLM: 101261221
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
07
06
2020
accepted:
08
06
2020
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
23
10
2020
Statut:
ppublish
Résumé
Novel corona virus disease 2019 (COVID-19) is an ongoing pandemic that has impacted the entire world. The Indian government has responded strongly and very stringently to the crisis, through a nationwide lockdown. The health-care (HC) systems in the country are striving hard to maintain equitable care across illness spectra, while responding the emergencies imposed by the COVID-19 crisis. Under these circumstances, guidelines for managing several diseases including that for cancer care have been modified. As modified guidelines for cancer care have their focus on disease management, cancer pain management and maintaining continuity of care for patients with advanced progressive disease have taken a backseat in the available cancer care guidelines. This article describes the challenges, approaches to solutions with evidence-based practices that can be utilized to ensure competent management of cancer pain during the COVID-19 pandemic in India. It provides an overview of adapting to telehealth consultations for identification, evaluation and management of cancer pain, safe and rational use of analgesics and adjuvant drugs, recognizing and responding to holistic care needs and addressing the total pain, ensuring continuity of pain management, and strategies when complying with narcotic drug regulations, while ensuring safety of patients and HC providers.
Identifiants
pubmed: 33088099
doi: 10.4103/IJPC.IJPC_216_20
pii: IJPC-26-106
pmc: PMC7535004
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S106-S115Informations de copyright
Copyright: © 2020 Indian Journal of Palliative Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Sci Total Environ. 2020 Aug 1;728:138882
pubmed: 32335410
Curr Oncol. 2008 Jan;15(Suppl 1):S41-9
pubmed: 18231648
CMAJ. 2013 May 14;185(8):E352
pubmed: 23509136
Asian Pac J Cancer Prev. 2020 Mar 01;21(3):569-573
pubmed: 32212779
N Engl J Med. 2020 May 14;382(20):e61
pubmed: 32343498
Pain Pract. 2017 Mar;17(3):409-419
pubmed: 27207115
J Pain Symptom Manage. 2002 Nov;24(5):526-42
pubmed: 12547052
J Natl Compr Canc Netw. 2013 Aug;11(8):992-1022
pubmed: 23946177
Pain Pract. 2008 Jul-Aug;8(4):287-313
pubmed: 18503626
Neuroimmunomodulation. 2004;11(4):255-60
pubmed: 15249732
J Neuroimmunol. 1998 Mar 15;83(1-2):19-28
pubmed: 9610669
Clin J Pain. 2010 Jun;26(5):374-80
pubmed: 20473043
J Pain Symptom Manage. 2016 Jun;51(6):1070-1090.e9
pubmed: 27112310
Saudi J Anaesth. 2013 Jul;7(3):322-6
pubmed: 24015138
Clin Oncol (R Coll Radiol). 2011 Aug;23(6):407-17
pubmed: 21576011
Anesth Analg. 2018 Aug;127(2):529-538
pubmed: 29239947
Lancet. 2020 Apr 25;395(10233):1315
pubmed: 32334687
Am J Hosp Palliat Care. 2012 Feb;29(1):70-9
pubmed: 21712306
Clinicoecon Outcomes Res. 2018 Nov 02;10:675-691
pubmed: 30464561
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
Trends Cancer. 2020 Jul;6(7):533-535
pubmed: 32386875
BMJ. 2020 Mar 26;368:m1251
pubmed: 32217534
Indian J Surg Oncol. 2020 Apr 29;:1-2
pubmed: 32351285
Crit Rev Oncol Hematol. 2020 Jun;150:102972
pubmed: 32344317
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Breast. 2020 Aug;52:8-16
pubmed: 32334323
Br J Anaesth. 2019 Aug;123(2):e412-e423
pubmed: 31122736
Anaesthesia. 2020 Jul;75(7):935-944
pubmed: 32259288
Ann Intern Med. 2015 Feb 17;162(4):276-86
pubmed: 25581257
Curr Opin Support Palliat Care. 2012 Mar;6(1):1-9
pubmed: 22246043
Palliat Med. 2012 Jun;26(4):305-12
pubmed: 22126843